is semaglutide still on the shortage list As of February 21, 2025, FDA updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A GLP-1 No Longer on FDA's

Disclaimer: These statements have not been evaluated by the FDA

PlexusDx provides personalized compounded semaglutide injections with flexible dosing and transparent flat monthly pricing

Natural GLP-1 Supplement: Struggling with cravings

Medical weight loss support with GLP-1 medications at Sweetgrass in Charleston, SC

Safety issues like the black box warning for thyroid cancer risk are also addressed

The researchers were able to measureGLP-1 in synovial fluid - the liquid within joint cavities - of patients with inflammatory rheumatic diseases. That matters becauseGLP-1-based therapies typically lead to much higher systemic exposure